NCT05480150View on ClinicalTrials.gov

Chinese Longitudinal and Systematic Study of Bioplar Disorder

NARecruitingINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Major Depressive DisorderBipolar Disorder, MixedAffective; Disorder, Organic
Interventions
DRUG

Escitalopram Oxalate Tablets

Starting at 5mg qn, the treatment dose was titrated to 10-20mg qn within 1 week and maintained for 4 weeks

DRUG

Quetiapine Fumarate Tablets

Starting at 50mg qn, the treatment dose was titrated to 300-400mg qn within 10 days, and maintained the treatment for 4 weeks.

DRUG

Lurasidone

Starting at 20mg qn, the treatment dose was titrated to 40mg qn within 6 days,and maintained the treatment for 4 weeks.

Trial Locations (1)

310000

RECRUITING

The First Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER